vs

Side-by-side financial comparison of CORCEPT THERAPEUTICS INC (CORT) and Ribbon Communications Inc. (RBBN). Click either name above to swap in a different company.

CORCEPT THERAPEUTICS INC is the larger business by last-quarter revenue ($202.1M vs $162.6M, roughly 1.2× Ribbon Communications Inc.). Ribbon Communications Inc. runs the higher net margin — 54.8% vs 12.0%, a 42.8% gap on every dollar of revenue. On growth, CORCEPT THERAPEUTICS INC posted the faster year-over-year revenue change (11.1% vs -10.3%). Over the past eight quarters, CORCEPT THERAPEUTICS INC's revenue compounded faster (17.3% CAGR vs -8.1%).

Corcept Therapeutics Inc. is a pharmaceutical company engaged in the discovery, development and commercialization of drugs for the treatment of severe metabolic, psychiatric and oncologic disorders. Corcept has focused on the adverse effects of excess cortisol, studying new compounds that may mitigate those effects. Its executive team is headed by CEO, president and director Joseph K. Belanoff, MD.

Ribbon Communications Inc. is a public company that makes software, IP and optical networking solutions for service providers, enterprises and critical infrastructure sectors. The company was formed in 2017, following the merger of Genband and Sonus Networks and is headquartered in Plano, Texas.

CORT vs RBBN — Head-to-Head

Bigger by revenue
CORT
CORT
1.2× larger
CORT
$202.1M
$162.6M
RBBN
Growing faster (revenue YoY)
CORT
CORT
+21.4% gap
CORT
11.1%
-10.3%
RBBN
Higher net margin
RBBN
RBBN
42.8% more per $
RBBN
54.8%
12.0%
CORT
Faster 2-yr revenue CAGR
CORT
CORT
Annualised
CORT
17.3%
-8.1%
RBBN

Income Statement — Q4 FY2025 vs Q1 FY2026

Metric
CORT
CORT
RBBN
RBBN
Revenue
$202.1M
$162.6M
Net Profit
$24.3M
$89.1M
Gross Margin
98.7%
42.9%
Operating Margin
2.2%
37.6%
Net Margin
12.0%
54.8%
Revenue YoY
11.1%
-10.3%
Net Profit YoY
-21.0%
EPS (diluted)
$0.20
$0.50

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CORT
CORT
RBBN
RBBN
Q1 26
$162.6M
Q4 25
$202.1M
$227.3M
Q3 25
$207.6M
$215.4M
Q2 25
$194.4M
$220.6M
Q1 25
$157.2M
$181.3M
Q4 24
$181.9M
$251.4M
Q3 24
$182.5M
$210.2M
Q2 24
$163.8M
$192.6M
Net Profit
CORT
CORT
RBBN
RBBN
Q1 26
$89.1M
Q4 25
$24.3M
Q3 25
$19.7M
$-12.1M
Q2 25
$35.1M
$-11.1M
Q1 25
$20.5M
$-26.2M
Q4 24
$30.7M
Q3 24
$47.2M
$-13.4M
Q2 24
$35.5M
$-16.8M
Gross Margin
CORT
CORT
RBBN
RBBN
Q1 26
42.9%
Q4 25
98.7%
53.3%
Q3 25
97.8%
50.1%
Q2 25
98.2%
49.6%
Q1 25
98.5%
45.4%
Q4 24
98.4%
55.7%
Q3 24
98.4%
52.1%
Q2 24
98.5%
50.8%
Operating Margin
CORT
CORT
RBBN
RBBN
Q1 26
37.6%
Q4 25
2.2%
4.1%
Q3 25
4.9%
1.3%
Q2 25
13.7%
1.9%
Q1 25
2.2%
-10.8%
Q4 24
13.9%
13.2%
Q3 24
25.5%
-0.4%
Q2 24
21.7%
-1.0%
Net Margin
CORT
CORT
RBBN
RBBN
Q1 26
54.8%
Q4 25
12.0%
Q3 25
9.5%
-5.6%
Q2 25
18.1%
-5.0%
Q1 25
13.1%
-14.5%
Q4 24
16.9%
Q3 24
25.9%
-6.4%
Q2 24
21.7%
-8.7%
EPS (diluted)
CORT
CORT
RBBN
RBBN
Q1 26
$0.50
Q4 25
$0.20
$0.50
Q3 25
$0.16
$-0.07
Q2 25
$0.29
$-0.06
Q1 25
$0.17
$-0.15
Q4 24
$0.25
$0.05
Q3 24
$0.41
$-0.08
Q2 24
$0.32
$-0.10

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CORT
CORT
RBBN
RBBN
Cash + ST InvestmentsLiquidity on hand
$372.2M
$67.6M
Total DebtLower is stronger
Stockholders' EquityBook value
$647.8M
$419.1M
Total Assets
$836.7M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CORT
CORT
RBBN
RBBN
Q1 26
$67.6M
Q4 25
$372.2M
$96.4M
Q3 25
$421.7M
$74.8M
Q2 25
$342.2M
$60.5M
Q1 25
$322.8M
$71.2M
Q4 24
$383.3M
$87.8M
Q3 24
$380.3M
$37.2M
Q2 24
$473.2M
$64.6M
Total Debt
CORT
CORT
RBBN
RBBN
Q1 26
Q4 25
$342.1M
Q3 25
$344.3M
Q2 25
$346.5M
Q1 25
$347.4M
Q4 24
$348.3M
Q3 24
$349.1M
Q2 24
$350.0M
Stockholders' Equity
CORT
CORT
RBBN
RBBN
Q1 26
$419.1M
Q4 25
$647.8M
$449.0M
Q3 25
$631.9M
$360.1M
Q2 25
$635.8M
$370.4M
Q1 25
$683.3M
$381.8M
Q4 24
$679.6M
$404.6M
Q3 24
$638.8M
$395.5M
Q2 24
$596.2M
$405.0M
Total Assets
CORT
CORT
RBBN
RBBN
Q1 26
Q4 25
$836.7M
$1.2B
Q3 25
$823.6M
$1.1B
Q2 25
$801.7M
$1.1B
Q1 25
$846.5M
$1.1B
Q4 24
$840.6M
$1.2B
Q3 24
$784.3M
$1.1B
Q2 24
$714.6M
$1.1B
Debt / Equity
CORT
CORT
RBBN
RBBN
Q1 26
Q4 25
0.76×
Q3 25
0.96×
Q2 25
0.94×
Q1 25
0.91×
Q4 24
0.86×
Q3 24
0.88×
Q2 24
0.86×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CORT
CORT
RBBN
RBBN
Operating Cash FlowLast quarter
$38.4M
Free Cash FlowOCF − Capex
$38.4M
FCF MarginFCF / Revenue
19.0%
Capex IntensityCapex / Revenue
0.0%
Cash ConversionOCF / Net Profit
1.58×
TTM Free Cash FlowTrailing 4 quarters

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CORT
CORT
RBBN
RBBN
Q1 26
Q4 25
$38.4M
$29.2M
Q3 25
$54.5M
$26.5M
Q2 25
$43.9M
$-795.0K
Q1 25
$5.1M
$-3.5M
Q4 24
$59.3M
$61.8M
Q3 24
$73.8M
$-14.8M
Q2 24
$41.2M
$-9.8M
Free Cash Flow
CORT
CORT
RBBN
RBBN
Q1 26
Q4 25
$38.4M
$27.3M
Q3 25
$21.0M
Q2 25
$43.9M
$-6.5M
Q1 25
$5.0M
$-15.7M
Q4 24
$59.2M
$53.8M
Q3 24
$72.2M
$-23.7M
Q2 24
$40.8M
$-12.9M
FCF Margin
CORT
CORT
RBBN
RBBN
Q1 26
Q4 25
19.0%
12.0%
Q3 25
9.7%
Q2 25
22.6%
-2.9%
Q1 25
3.2%
-8.7%
Q4 24
32.5%
21.4%
Q3 24
39.5%
-11.3%
Q2 24
24.9%
-6.7%
Capex Intensity
CORT
CORT
RBBN
RBBN
Q1 26
Q4 25
0.0%
0.9%
Q3 25
0.0%
2.6%
Q2 25
0.0%
2.6%
Q1 25
0.1%
6.7%
Q4 24
0.1%
3.2%
Q3 24
0.9%
4.2%
Q2 24
0.3%
1.6%
Cash Conversion
CORT
CORT
RBBN
RBBN
Q1 26
Q4 25
1.58×
Q3 25
2.77×
Q2 25
1.25×
Q1 25
0.25×
Q4 24
1.93×
Q3 24
1.56×
Q2 24
1.16×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

CORT
CORT

Segment breakdown not available.

RBBN
RBBN

Service$94.5M58%
Product$68.1M42%

Related Comparisons